dipyridamole has been researched along with Esophageal Varices in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brady, L | 1 |
| Magilavy, D | 1 |
| Black, DD | 1 |
| Fisher, RS | 1 |
| Cohen, S | 1 |
2 other studies available for dipyridamole and Esophageal Varices
| Article | Year |
|---|---|
Portal vein thrombosis associated with antiphospholipid antibodies in a child.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Child, Preschool; Dipyridamole; Esophageal a | 1996 |
Disorders of the lower esophageal sphincter.
Topics: Acetylcholine; Chagas Disease; Dipyridamole; Esophageal Achalasia; Esophageal and Gastric Varices; E | 1975 |